GFB-887

N/A

Report date: 2025/04/20 20:00:03
NME

Base Information

Drug NameGFB-887
Drug Alias NameDN-007GFB-887PKD-003PKD-004PKD-005 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionShort transient receptor potential channel 5 blockersShort transient receptor potential channel 4 inhibitors
TargetsShort transient receptor potential channel 5Short transient receptor potential channel 4
Therapy Area/IndicationsDiabetes ComplicationsEndocrine System DiseasesDiabetes Mellitus +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGoldfinch Bio IncGilead Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKaruna Therapeutics IncGoldfinch Bio Inc
Active IndicationsN/A
Inactive IndicationsDiabetes ComplicationsEndocrine System DiseasesDiabetes Mellitus +[11] 

Other Information

ATC CodeN/A
Related LinksN/A